We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$423M
AUM Growth
-$85.6M
Cap. Flow
-$118M
Cap. Flow %
-27.88%
Top 10 Hldgs %
66.33%
Holding
83
New
3
Increased
17
Reduced
15
Closed
37

Top Buys

Rank Stock Value
1
CNNE icon
Cannae Holdings
CNNE
+$14.6M
2
GTX icon
Garrett Motion
GTX
+$11.9M
3
CIO
City Office REIT
CIO
+$8.27M
4
MBI icon
MBIA
MBI
+$2.91M
5
VTOL icon
Bristow Group
VTOL
+$2.74M

Top Sells

Rank Stock Value
1
LW icon
Lamb Weston
LW
+$15.4M
2
GTXAP
Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock
GTXAP
+$15.1M
3
ADNT icon
Adient
ADNT
+$14.1M
4
CUBI icon
Customers Bancorp
CUBI
+$11.6M
5
AVTA
Avantax, Inc. Common Stock
AVTA
+$10.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.61%
2 Healthcare 22.7%
3 Communication Services 13.35%
4 Real Estate 8.73%
5 Technology 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYT
26
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$3.53M 0.83%
1,358,049
+405,102
+43% +$848K
PFSW
27
DELISTED
PFSweb, Inc.
PFSW
$3.37M 0.8%
746,406
+30,524
+4% +$127K
AMPY icon
28
Amplify Energy
AMPY
$155M
$2.66M 0.63%
393,214
-744,632
-65% -$5.19M
FTH
29
Faeth Therapeutics
FTH
$754M
$2.08M 0.49%
91,362
+14,316
+19% +$419K
WVE icon
30
Wave Life Sciences
WVE
$1.14B
$1.82M 0.43%
500,000
-14,028
-3% -$56.7K
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.69M 0.4%
+764,274
New +$1.59M
ADVM
32
DELISTED
Adverum Biotechnologies
ADVM
$1.59M 0.38%
100,000
-52,840
-35% -$556K
OLMA icon
33
Olema Pharmaceuticals
OLMA
$1.05B
$1.58M 0.37%
175,000
-200,000
-53% -$1.21M
BOLT icon
34
Bolt Biotherapeutics
BOLT
$7.63M
$1.28M 0.3%
50,000
-5,756
-10% -$183K
BDTX icon
35
Black Diamond Therapeutics
BDTX
$99.1M
$1.01M 0.24%
200,000
-106,609
-35% -$218K
ALGS icon
36
Aligos Therapeutics
ALGS
$25.2M
$874K 0.21%
36,000
-4,858
-12% -$130K
DBTX
37
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$770K 0.18%
200,000
-53,818
-21% -$197K
ORKA
38
Oruka Therapeutics
ORKA
$5.44B
$636K 0.15%
26,100
-17,214
-40% -$424K
AVIR icon
39
Atea Pharmaceuticals
AVIR
$386M
$334K 0.08%
+89,197
New +$334K
LW icon
40
Lamb Weston
LW
$7.3B
$248K 0.06%
2,157
-137,843
-98% -$15.4M
GBTG icon
41
American Express Global Business Travel
GBTG
$4.91B
$224K 0.05%
30,923
-1,027,275
-97% -$7M
BRLIR
42
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$63.8K 0.02%
457,409
– –
ARIZR
43
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$22.2K 0.01%
250,000
– –
LFLYW
44
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$19.2K ﹤0.01%
634,640
– –
VHAQ.RT
45
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$14.3K ﹤0.01%
250,000
– –
ADNT icon
46
Adient
ADNT
$1.62B
– –
-345,000
Closed -$14.1M
ALEC icon
47
Alector
ALEC
$168M
– –
-155,000
Closed -$959K
AMR icon
48
Alpha Metallurgical Resources
AMR
$1.85B
– –
-6,319
Closed -$986K
ATAI icon
49
AtaiBeckley Inc
ATAI
$2.65B
– –
-960,000
Closed -$1.74M
BKU icon
50
Bankunited
BKU
$3.36B
– –
-80,000
Closed -$1.81M
1
2
3 4

Similar funds

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Newtyn Management's Q2 2023 Portfolio in Review

As of Q2 2023, Newtyn Management held 83 positions worth $423M, down 17% from $509M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Newtyn Management withdrew a net $118M in Q2 2023, closing 37 positions and reducing 15 holdings. Its most notable exit was Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Newtyn Management opened a new position in Garrett Motion worth $11.2M.

  • Newtyn Management's largest Q2 2023 buy was Garrett Motion: 1,482,149 shares worth $11.2M.
  • Newtyn Management added most to Cannae Holdings in Q2 2023, an estimated $14.6M increase.
  • Newtyn Management's biggest Q2 2023 reduction was Lamb Weston, cutting an estimated $15.4M.
  • Newtyn Management fully exited Garrett Motion Inc. Series A Cumulative Convertible Preferred Stock in Q2 2023, selling an estimated $15.1M.
  • Newtyn Management's ten largest holdings make up 66% of its $423M portfolio in Q2 2023.
  • Newtyn Management opened 3 new positions and closed 37 in Q2 2023.
  • Newtyn Management's portfolio value fell 17% quarter-over-quarter to $423M.

Based on Newtyn Management's 13F filing for Q2 2023, filed 14 Aug 2023.